Dexcom is pleased to sponsor a quarterly podcast series to complement Diabetes Technology & Therapeutics. The podcast series features prominent medical doctors and certified diabetes educators discussing continuos glucose monitoring (CGM), data, Dexcom G6 and more.
In episode #1 of The Dexcom Podcast Series, Dr. Satish Garg, Editor-in-Chief of Diabetes Technology and Therapeuticsintroduces Dr. Andrew Ahmann and work featured in his manuscript entitled Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.
In episode #2 of the Dexcom Podcast Series, Dr. Irl Hirsch and Dr. William Polonsky review the lack of data of CGM in patients with type 1 diabetes receiving multiple daily injections. They discuss the GOLD Study main results and delve deeper into the further analysis of hypoglycemia reduction at night and during the day, and how this improved hypoglycemia-related confidence when using CGM.
In episode #3 of the Dexcom Podcast Series, Dr. Paul Wadwa and Dr. Viral Shah review the Dexcom G6 CGM accuracy data in patients with type 1 diabetes and insulin-treated patients with type 2 diabetes. They discuss the accuracy of this CGM, accuracy of hypo and hyperglycemia alerts, and a brief explanation of CGM lag time, FDA classification for device approval, and the significance of an interoperable CGM.
Visit the Dexcom Learning Center to find all previous episodes.
Our Chairman and CEO, Kevin Sayer, was on Mad Money with Jim Cramer to discuss our CGM technology and the successful year Dexcom had in 2018.
November is National Diabetes Awareness Month, a time when communities across the country bring attention to the impact and treatment of diabetes.